These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17287139)
1. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden. Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139 [TBL] [Abstract][Full Text] [Related]
2. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Xue S; Jia J Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667 [TBL] [Abstract][Full Text] [Related]
3. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Mellick GD; Silburn PA Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850 [TBL] [Abstract][Full Text] [Related]
4. Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson's disease in the Chinese population. Wang L; Guo JF; Nie LL; Luo L; Zuo X; Shen L; Jiang H; Yan XX; Xia K; Pan Q; Tang BS J Clin Neurosci; 2011 Apr; 18(4):541-4. PubMed ID: 21315600 [TBL] [Abstract][Full Text] [Related]
5. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells. Kyratzi E; Pavlaki M; Stefanis L Hum Mol Genet; 2008 Jul; 17(14):2160-71. PubMed ID: 18411255 [TBL] [Abstract][Full Text] [Related]
6. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1. Tse HS; Hu HY; Sze KH Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373 [TBL] [Abstract][Full Text] [Related]
7. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Maraganore DM; Farrer MJ; Hardy JA; Lincoln SJ; McDonnell SK; Rocca WA Neurology; 1999 Nov; 53(8):1858-60. PubMed ID: 10563640 [TBL] [Abstract][Full Text] [Related]
9. UCH-L1 S18Y variant and risk of Parkinson's disease in Asian populations: an updated meta-analysis. Zhu R; Zhu Y; Liu X; He Z Neurodegener Dis; 2014; 14(4):194-203. PubMed ID: 25471998 [TBL] [Abstract][Full Text] [Related]
10. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. Satoh J; Kuroda Y J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241 [TBL] [Abstract][Full Text] [Related]
11. [Association of the ubiquitin carboxy-terminal hydrolase-L1 genetic polymorphism with the susceptibility of Parkinson's disease]. Xiao Y; Zhang B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):586-7. PubMed ID: 18841579 [TBL] [Abstract][Full Text] [Related]
12. [Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson's disease in Shanghai]. Hao YX; Zhang J; Fang CP; Zhang Q; Zhang JR; Shen Q Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):272-5. PubMed ID: 18543214 [TBL] [Abstract][Full Text] [Related]
13. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903 [TBL] [Abstract][Full Text] [Related]
14. Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age. Liu Y; Chen YY; Liu H; Yao CJ; Zhu XX; Chen DJ; Yang J; Lu YJ; Cao JY Neurol Sci; 2015 Feb; 36(2):179-88. PubMed ID: 25370916 [TBL] [Abstract][Full Text] [Related]
15. Case-control study of UCHL1 S18Y variant in Parkinson's disease. Tan EK; Puong KY; Fook-Chong S; Chua E; Shen H; Yuen Y; Pavanni R; Wong MC; Puvan K; Zhao Y Mov Disord; 2006 Oct; 21(10):1765-8. PubMed ID: 16941465 [TBL] [Abstract][Full Text] [Related]
16. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440 [TBL] [Abstract][Full Text] [Related]
17. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders. Lee YC; Hsu SD Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237 [TBL] [Abstract][Full Text] [Related]
18. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset. Wang J; Zhao CY; Si YM; Liu ZL; Chen B; Yu L Mov Disord; 2002 Jul; 17(4):767-71. PubMed ID: 12210873 [TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population. Zhang ZJ; Burgunder JM; An XK; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Mao XY; Peng R Neurosci Lett; 2008 Sep; 442(3):200-2. PubMed ID: 18638528 [TBL] [Abstract][Full Text] [Related]
20. The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1. Andersson FI; Werrell EF; McMorran L; Crone WJ; Das C; Hsu ST; Jackson SE J Mol Biol; 2011 Mar; 407(2):261-72. PubMed ID: 21251915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]